Life sciences, Respiratory medicine

Treatment response and prognosis prediction of immune checkpoint inhibitors by FDG-PET/CT: A Japanese multicenter prospective study
Grant-in-Aid for Scientific Research (C)
Hyogo Medical University
01 Apr. 2022 - 31 Mar. 2026

呼吸動態の力学的な理解にもとづいた呼吸器疾患の新規診断法の開発
基盤研究(C)
兵庫医科大学
01 Apr. 2021 - 31 Mar. 2024

肺癌治療において分子標的治療薬が惹起する薬剤性肺障害の発症機序の解明とその克服
基盤研究(C)
兵庫医科大学
01 Apr. 2020 - 31 Mar. 2023

Identification of molecular mechanism underlying malignant mesothelioma development using conditional mouse model and search of therapeutic target molecules
Grant-in-Aid for Scientific Research (C)
Hyogo Medical University
01 Apr. 2018 - 31 Mar. 2021

Development of innovative nucleic acid medicine using EPR enhancer iNaD
Grant-in-Aid for Scientific Research (A)
Osaka University
01 Apr. 2018 - 31 Mar. 2021

Developing novel lung cancer therapy targetting cancer cell intrinsic ligands
Grant-in-Aid for Scientific Research (C)
Osaka University
01 Apr. 2015 - 31 Mar. 2018

HER2 target therapy for multidrug-resistant small cell lung cancer
Grant-in-Aid for Scientific Research (C)
Osaka University
01 Apr. 2012 - 31 Mar. 2015

Molecular target therapy for multidrug-resistant small cell lung cancer
Grant-in-Aid for Scientific Research (C)
Osaka University
2009 - 2011

The Induction of Decsity-Deoendent Inhibition of Cell Growth in Malignant Mesothelioma Cells by the Extracellular Domain of erbB2 for Reduction of Growth of Mesothelioma
Grant-in-Aid for Scientific Research (C)
Osaka University
2005 - 2006